Incidental Finding of Intrathyroid Metastases of Prostatic Cancer on 18F-Choline PET/CT

被引：4

作者：

Racaru, Lavinia Vija ^{[1
]}

Gabiache, Erwan ^{[1
,2
]}

Fontaine, Sebastien ^{[1
,3
]}

D'Aure, Dominique ^{[4
]}

Mourey, Loic ^{[5
]}

Courbon, Frederic ^{[1
]}

Zerdoud, Slimane ^{[1
]}

机构：

[1] Inst Claudius Regaud, Inst Univ Cancerol Oncopole, Nucl Med Dept, 1 Ave Irene Joliot Curie, F-31100 Toulouse, France

[2] Pasteur Clin, Nucl Med Dept, Toulouse, France

[3] Joseph Ducuing Hosp, Dept Endocrinol, Toulouse, France

[4] CHU Toulouse, Dept Pathol, Toulouse, France

[5] Inst Claudius Regaud, Inst Univ Cancerol Oncopole, Dept Oncol, Toulouse, France

来源：

CLINICAL NUCLEAR MEDICINE | 2019年 / 44卷 / 02期

关键词：

fluorocholine PET/CT; intrathyroid metastases; prostate cancer; RELAPSE;

D O I：

10.1097/RLU.0000000000002374

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

An 85-year-old man with a 2-year history of prostate cancer, treated with radiotherapy and hormonal therapy, presented increased prostatic-specific antigen levels. F-18-choline PET/CT showed focal prostatic uptake consistent with known local recurrence, increased uptake of 2 hypodense thyroid nodules and of 2 left cervical lymph nodes, suspected as thyroid cancer. Neck ultrasound confirmed the high risk of malignancy, and a guided biopsy (of a thyroid nodule and cervical lymph node) revealed cellular infiltrates thyroid transcription factor-1 (TTF-1) negative and prostatic-specific antigen positive, confirming intrathyroid and cervical lymph node metastases of prostate cancer. PET/CT changed the disease staging. Chemotherapy was initiated.

引用

页码：E101 / E103

页数：3

共 50 条

[21] 18F-Choline PET/CT in Biochemical Recurrence of Prostate Cancer
Riola-Parada, C.
Lucas-Velazquez, B.
Gomez-Caminero, F.
Villanueva, J.
Garcia-Talavera, P.
Diaz, L.
Penaherrera, A.
Canadas Salazar, J.
Tamayo, M.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S592 - S592
[22] Pitfalls with 18F-Choline PET/CT in patients with prostate cancer
Garcia Vicente, A. M.
Nunez Garcia, A.
Soriano Castrejon, A. M.
Jimenez Londono, G. A.
Cordero Garcia, J. M.
Palomar Munoz, A.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2013, 32 (01): : 37 - 39
[23] Protocol for PET with CT 18F-Choline Implementation
Acaina-Perez, A.
Pareja-Cano, A.
Canete-Cordoba, E.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S457 - S458
[24] 18F-Choline PET/CT in biochemically relapsed prostate cancer
Marzola, Maria Cristina
Chondrogiannis, Sotirios
Grassetto, Gaia
Rampin, Lucia
Ferretti, Alice
Massaro, Arianna
Fornasiero, Adriano
Rubello, Domenico
JOURNAL OF NUCLEAR MEDICINE, 2012, 53
[25] 18F-Choline PET/CT for Parathyroid Scintigraphy
不详
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 17N - 18N
[26] Incidental detection of Hurthle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer
Paone, G.
Treglia, G.
Bongiovanni, M.
Ruberto, T.
Ceriani, L.
Giovanella, L.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2013, 32 (05): : 340 - 341
[27] Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer
Goineau, Aurore
Colombie, Mathilde
Rousseau, Caroline
Sadot-Lebouvier, Sophie
Supiot, Stephane
CLINICAL NUCLEAR MEDICINE, 2015, 40 (08) : 670 - 671
[28] Re: Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer
Evangelista, Laura
Pasquale, Reccia
CLINICAL NUCLEAR MEDICINE, 2016, 41 (09) : 746 - 746
[29] A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer
Wondergem, Maurits
van der Zant, Friso M.
van der Ploeg, Tjeerd
Knol, Remco J. J.
NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (10) : 935 - 945
[30] Diagnostic performance of 18F-choline PET-CT in prostate cancer
P. Samper Ots
A. Luis Cardo
C. Vallejo Ocaña
M. A. Cabeza Rodríguez
L. A. Glaria Enríquez
M. L. Couselo Paniagua
J. Olivera Vegas
Clinical and Translational Oncology, 2019, 21 : 766 - 773

← 1 2 3 4 5 →